...
首页> 外文期刊>Medicine. >Familial Mediterranean Fever in Japan
【24h】

Familial Mediterranean Fever in Japan

机译:日本的家族性地中海热

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Abstract: Familial Mediterranean fever (FMF) is a hereditary autoinflammatory disease that is prevalent in Mediterranean populations. While it is considered a rare disease in the rest of world, a significant number of FMF patients have been reported in East Asia, including Japan. Our aim was to determine the prevalence of FMF in Japan and elucidate the clinical and genetic features of Japanese patients. A primary nationwide survey of FMF was conducted between January and December 2009. Hospitals specializing in pediatrics and hospitals with pediatric, internal medicine, and rheumatology/allergy departments were asked to report all patients with FMF during the survey year. The estimated total number of Japanese FMF patients was 292 (95% confidence interval, 187–398 people). We evaluated the clinical and genetic profiles of Japanese patients from the data obtained in a secondary survey of 134 FMF patients. High-grade fever was observed in 95.5%, chest pain (pleuritis symptoms) in 36.9%, abdominal pain (peritonitis symptoms) in 62.7%, and arthritis in 31.3%. Of the patients profiled, 25.4% of patients experienced their first attack before 10 years of age, 37.3% in their teens, and 37.3% after age 20 years. Colchicine was effective in 91.8% of patients at a relatively low dose (mean dose, 0.89 ± 0.45 mg/d). AA amyloidosis was confirmed in 5 patients (3.7%). Of the 126 patients studied, 109 (86.5%) were positive for 1 or more genetic mutations and 17 (13.5%) had no mutation detected. Common Mediterranean fever gene (MEFV) mutations were E148Q/M694I (19.8%) and M694Iormal (12.7%). The differences in the prevalence of peritonitis, pleuritis, and a family history of FMF were statistically significant between FMF patients with MEFV exon 10 mutations compared with those without exon 10 mutations. In conclusion, a significant number of patients with FMF exist in Japan. Although Japanese patients with FMF are clinically or genetically different from Mediterranean patients, the delay in diagnosis is an issue that should be resolved.
机译:摘要:家族性地中海热(FMF)是一种遗传性自发性炎症,在地中海地区人群中普遍存在。尽管它被认为是世界上罕见的疾病,但在包括日本在内的东亚地区已经报告了许多FMF患者。我们的目的是确定FMF在日本的患病率,并阐明日本患者的临床和遗传特征。 2009年1月至12月在全国范围内对FMF进行了一次主要调查。调查期间,要求儿科专科医院和儿科,内科以及风湿病/过敏科的医院报告所有FMF患者。日本FMF患者的估计总数为292(95%置信区间,187-398人)。我们从对134名FMF患者的二次调查中获得的数据评估了日本患者的临床和遗传特征。观察到高烧为95.5%,胸痛(胸膜炎症状)为36.9%,腹痛(腹膜炎症状)为62.7%,关节炎为31.3%。在接受调查的患者中,有25.4%的患者在10岁之前经历了第一次发作,在青少年中为37.3%,在20岁之后经历了37.3%。秋水仙碱以相对较低的剂量(平均剂量为0.89±0.45 mg / d)对91.8%的患者有效。在5例患者中确认了AA淀粉样变性(3.7%)。在研究的126例患者中,有109个(86.5%)对1个或多个基因突变呈阳性,而17例(13.5%)没有检测到突变。常见的地中海热病基因(MEFV)突变为E148Q / M694I(19.8%)和M694I /正常(12.7%)。具有MEFV第10外显子突变的FMF患者与没有第10外显子突变的FMF患者之间的腹膜炎,胸膜炎和FMF家族史的患病率差异具有统计学意义。总之,日本存在大量的FMF患者。尽管日本的FMF患者在临床或遗传上与地中海患者不同,但诊断延迟是一个应解决的问题。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号